May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Quality of Life and the Spectrum of Glaucoma
Author Affiliations & Notes
  • K. J. Warrian
    Glaucoma Research Center, Wills Eye Institute of Jefferson Medical College, Philadelphia, Pennsylvania
  • L. L. Lorenzana
    Glaucoma Research Center, Wills Eye Institute of Jefferson Medical College, Philadelphia, Pennsylvania
  • G. L. Spaeth
    Glaucoma Research Center, Wills Eye Institute of Jefferson Medical College, Philadelphia, Pennsylvania
  • Footnotes
    Commercial Relationships K.J. Warrian, None; L.L. Lorenzana, None; G.L. Spaeth, None.
  • Footnotes
    Support Pfizer, The Perelman Fund through the Wills Eye Institute, The Pearle Vision Foundation, The Glaucoma Service Foundation to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 1565. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. J. Warrian, L. L. Lorenzana, G. L. Spaeth; Quality of Life and the Spectrum of Glaucoma. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1565. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To determine the relationship between self-reported quality of life (QoL) and discrete stages of glaucomatous visual impairment.

 
Methods:
 

194 glaucoma patients ages 24-93, 98 female, 96 male, all without visually significant ocular comorbidity completed the 25-Item National Eye Institute’s Visual Functioning Questionnaire (VFQ) and monocular 24-2 SITA Standard Humphrey visual fields in each eye. Patients were grouped into five discrete stages of impairment using the Hodapp-Parrish-Anderson (HPA) grading system based on their worse seeing eyes. Statistical analysis was conducted to identify significant differences in self-reported QoL between patients with different stages of glaucomatous impairment.

 
Results:
 

Comparisons between early and late HPA stages were associated with increasing numbers of statistically significant differences in VFQ total and subscale scores. (Table 1) The earliest statistically significant differences in self-reported QoL existed between HPA groups 1 & 2 and related to driving.

 
Conclusions:
 

Patients generally remain asymptomatic until they have moderate to severe visual field loss in their worse seeing eye; however, earlier self-perceived limitations in driving may be present in the minimal to early stages of impairment.  

 
Keywords: quality of life • visual fields 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×